Trial Profile
A Phase 1, Open-label Study to Characterize the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Pimodivir (Primary)
- Indications Infections
- Focus Pharmacokinetics
- Sponsors Janssen-Cilag
- 23 Jul 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2015 New trial record